longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AIM

AIM
----

LongbridgeAI

AIM: Earnings rebounded on Bozzetto sale, with strong cash growth and ongoing cost discipline

Quartr
Aug 11, 2026 at 10:13 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Net earnings surged to $33.3 million from a $6.1 million loss year-over-year, driven by the $270 million Bozzetto sale and favorable FX. Revenue and Adjusted EBITDA declined, while cash reserves rose sharply. Focus remains on capital allocation, cost control, and Cortland turnaround.Original document: Aimia Inc. [AIM] Earnings Release — Aug. 11 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Net earnings surged to $33.3 million from a $6.1 million loss year-over-year, driven by the $270 million Bozzetto sale and favorable FX. Revenue and Adjusted EBITDA declined, while cash reserves rose sharply. Focus remains on capital allocation, cost control, and Cortland turnaround.

Original document: Aimia Inc. [AIM] Earnings Release — Aug. 11 2026

Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Login to unlock488characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

AIM ImmunoTech

AIM ImmunoTech

AIM.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--